1. Home
  2. ZYXI vs JRVR Comparison

ZYXI vs JRVR Comparison

Compare ZYXI & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZYXI
  • JRVR
  • Stock Information
  • Founded
  • ZYXI 1996
  • JRVR 2002
  • Country
  • ZYXI United States
  • JRVR Bermuda
  • Employees
  • ZYXI N/A
  • JRVR N/A
  • Industry
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • JRVR Property-Casualty Insurers
  • Sector
  • ZYXI Health Care
  • JRVR Finance
  • Exchange
  • ZYXI Nasdaq
  • JRVR Nasdaq
  • Market Cap
  • ZYXI 72.3M
  • JRVR 261.1M
  • IPO Year
  • ZYXI N/A
  • JRVR 2005
  • Fundamental
  • Price
  • ZYXI $2.62
  • JRVR $5.74
  • Analyst Decision
  • ZYXI Buy
  • JRVR Buy
  • Analyst Count
  • ZYXI 3
  • JRVR 4
  • Target Price
  • ZYXI $6.00
  • JRVR $6.06
  • AVG Volume (30 Days)
  • ZYXI 291.0K
  • JRVR 277.2K
  • Earning Date
  • ZYXI 07-24-2025
  • JRVR 08-04-2025
  • Dividend Yield
  • ZYXI N/A
  • JRVR 0.68%
  • EPS Growth
  • ZYXI N/A
  • JRVR N/A
  • EPS
  • ZYXI N/A
  • JRVR N/A
  • Revenue
  • ZYXI $172,401,000.00
  • JRVR $678,788,000.00
  • Revenue This Year
  • ZYXI N/A
  • JRVR $1.95
  • Revenue Next Year
  • ZYXI $19.55
  • JRVR $6.80
  • P/E Ratio
  • ZYXI N/A
  • JRVR N/A
  • Revenue Growth
  • ZYXI N/A
  • JRVR N/A
  • 52 Week Low
  • ZYXI $1.66
  • JRVR $3.00
  • 52 Week High
  • ZYXI $10.62
  • JRVR $8.99
  • Technical
  • Relative Strength Index (RSI)
  • ZYXI 61.26
  • JRVR 53.31
  • Support Level
  • ZYXI $2.30
  • JRVR $5.54
  • Resistance Level
  • ZYXI $2.58
  • JRVR $5.94
  • Average True Range (ATR)
  • ZYXI 0.16
  • JRVR 0.18
  • MACD
  • ZYXI 0.05
  • JRVR -0.06
  • Stochastic Oscillator
  • ZYXI 96.98
  • JRVR 39.22

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure, and the Corporate and other segment consists of the management and treasury activities of holding companies, and equity compensation for the group.

Share on Social Networks: